BTIG Reiterates Buy Rating on SBC Medical Group (SBC)
BTIG analyst Sam Eiber reiterated a Buy rating and $8.00 price target on SBC Medical Group (NASDAQ: SBC).The analyst commented ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
